{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:26:32Z","timestamp":1793298392844,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clinbiochem.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:32:35Z","timestamp":1625664755000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Anti-NR2 glutamate receptor antibodies as an early biomarker of cerebral small vessel disease"],"prefix":"10.1016","volume":"96","author":[{"given":"Larisa A.","family":"Dobrynina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia V.","family":"Alexandrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam R.","family":"Zabitova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila A.","family":"Kalashnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Krotenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulat M.","family":"Akhmetzyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2021.07.003_b0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0015","unstructured":"METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research. Alzheimers Dement. 2016, 12, 1235-1249. 10.1016\/j.jalz.2016.06.004."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0025","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jalz.2018.04.007","article-title":"Cerebral small vessel disease and the risk of dementia: A systematic review and meta-analysis of population-based evidence","volume":"14","author":"Bos","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c3666","article-title":"The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"341","author":"Debette","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0040","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1161\/STROKEAHA.115.011237","article-title":"World stroke organization. stroke and potentially preventable dementias proclamation: updated world stroke day proclamation","volume":"46","author":"Hachinski","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0045","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jnnp.2009.204685","article-title":"Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations","volume":"82","author":"Gouw","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001140","article-title":"What are white matter hyperintensities made of? Relevance to vascular cognitive impairment","volume":"4","author":"Wardlaw","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.neurobiolaging.2014.07.048","article-title":"White matter hyperintensities and normal-appearing white matter integrity in the aging brain","volume":"36","author":"Maniega","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","article-title":"Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations","volume":"15","author":"Thrippleton","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0070","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00520.2003","article-title":"Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor","volume":"285","author":"Sharp","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0075","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1523\/JNEUROSCI.0969-19.2019","article-title":"Nonionotropic Action of Endothelial NMDA Receptors on Blood-Brain Barrier Permeability via Rho\/ROCK-Mediated Phosphorylation of Myosin","volume":"40","author":"Mehra","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0080","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04302","article-title":"NMDA receptors are expressed in oligodendrocytes and activated in ischaemia","volume":"438","author":"K\u00e1rad\u00f3ttir","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-4547(19981215)54:6<814::AID-JNR9>3.0.CO;2-3","article-title":"Expression of glutamate receptors on cultured cerebral endothelial cells","volume":"54","author":"Krizbai","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042362","article-title":"Diagnostic potential of the NMDA receptor peptide assay for acute ischemic stroke","volume":"7","author":"Dambinova","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.02.003","article-title":"Biomarkers for stroke: in search of fingerprints","volume":"20","author":"Bettermann","year":"2011","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0105","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1373\/49.10.1752","article-title":"Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke","volume":"49","author":"Dambinova","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0110","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tips.2016.05.012","article-title":"Physiological Roles of Non-Neuronal NMDA Receptors","volume":"37","author":"Hogan-Cann","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0115","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01110.2003","volume":"288","author":"Sharp","year":"2005","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bcp.2006.09.021","article-title":"Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation. Version 2","volume":"73","author":"Scott","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcp.24722","article-title":"Hydrogen Sulfide Epigenetically Attenuates Homocysteine-Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells","volume":"230","author":"Kamat","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0130","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00702-014-1193-3","volume":"121","author":"Levite","year":"2014","journal-title":"J. Neural. Transm. (Vienna)."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0135","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2009.07.034","article-title":"Oxidative stress upregulates the NMDA receptor on cerebrovascular endothelium","volume":"47","author":"Betzen","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0140","doi-asserted-by":"crossref","first-page":"532","DOI":"10.12659\/MSM.912389","article-title":"Anti-N-Methyl-D-Aspartic Acid Receptor 2 (Anti-NR2) Antibody in Neuropsychiatric Lupus Serum Damages the Blood-Brain Barrier and Enters the Brain","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2010.09.023","article-title":"NR2 antibodies: risk assessment of transient ischemic attack (TIA)\/stroke in patients with history of isolated and multiple cerebrovascular events","volume":"300","author":"Weissman","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0150","series-title":"Stroke Biomarkers","year":"2020"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0155","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jns.2017.02.028","article-title":"Circulating autoantibodies against the NR2 peptide of the NMDA receptor are associated with subclinical brain damage in hypertensive patients with other pre-existing conditions for vascular risk","volume":"375","author":"Gonz\u00e1lez-Garc\u00eda","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0160","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0165","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer Dement."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer Dement."},{"issue":"31","key":"10.1016\/j.clinbiochem.2021.07.003_b0175","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"2013","author":"Mancia","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc.."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0185","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: DSM-5","first-page":"991","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0195","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/01.STR.28.3.652","article-title":"Pathogenesis of leukoaraiosis: a review","volume":"28","author":"Pantoni","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0200","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/archneur.58.10.1620","article-title":"The coagulation-fibrinolysis system in patients with leukoaraiosis and Binswanger disease","volume":"58","author":"Tomimoto","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000356789","article-title":"Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis","volume":"37","author":"Wiseman","year":"2014","journal-title":"Cerebrovasc Dis."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0210","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/brainsci9100266","article-title":"Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease","volume":"9","author":"Dobrynina","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2019.09.017","article-title":"White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed","volume":"85","author":"Freeze","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0220","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s00415-017-8550-8","article-title":"Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden","volume":"264","author":"Li","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0225","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1177\/0271678X16662891","article-title":"Cerebral blood flow in small vessel disease: A systematic review and meta-analysis","volume":"36","author":"Shi","year":"2016","journal-title":"J. Cereb. Blood. Flow. Metab."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0230","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s12035-017-0562-y","article-title":"Genetic Mutation of GluN2B Protects Brain Cells Against Stroke Damages","volume":"55","author":"Tang","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0235","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1023\/A:1024678112357","article-title":"Expression of NMDA neuroreceptors in experimental ischemia","volume":"68","author":"Gappoeva","year":"2003","journal-title":"Biochemistry (Mosc)."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0240","doi-asserted-by":"crossref","first-page":"25520","DOI":"10.1074\/jbc.M112.374397","article-title":"Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor","volume":"287","author":"Ng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0245","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.STR.0000221295.14547.c8","article-title":"NMDA receptor antibodies predict adverse neurological outcome after cardiac surgery in high-risk patients","volume":"37","author":"Bokesch","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1309\/LMZI8CEAATHRXR74","article-title":"N-methyl-D-aspartate\u2013Receptor Antibodies, S100B Protein, and Neuron-Specific Enolase Before and After Cardiac Surgery: Association with Ischemic Brain Injury and Erythropoetin Prophylaxis","volume":"44","author":"Skitek","year":"2013","journal-title":"Laboratory Medicine."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0255","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/970793","article-title":"Aortic Stiffness Is Related to the Ischemic Brain Injury Biomarker N-Methyl-D-aspartate Receptor Antibody Levels in Aortic Valve Replacement","volume":"2014","author":"Kidher","year":"2014","journal-title":"Neurol Res Int."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0260","first-page":"89","article-title":"The Value of Serum NR2 Antibody in Prediction of Post-Cardiopulmonary Resuscitation Survival","volume":"3","author":"Bidari","year":"2015","journal-title":"Emerg (Tehran)"},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.07.003_b0265","article-title":"Recombinant tissue plasminogen activator administration in patients with cerebrovascular accident; a case series","volume":"2","author":"Kasmaei","year":"2015","journal-title":"Archiv. Neurosci"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0270","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/01.STR.0000014922.83673.86","article-title":"Multiple panel of biomarkers for TIA\/stroke evaluation","volume":"33","author":"Dambinova","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0275","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/jcmm.12614","article-title":"GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases","volume":"19","author":"Stanca","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-011-0851-x","article-title":"Heterogeneity in age-related white matter changes","volume":"122","author":"Schmidt","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0290","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.STR.0000058480.77236.B3","article-title":"Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?","volume":"34","author":"Wardlaw","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0295","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.STR.0000221308.94473.14","article-title":"White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury","volume":"37","author":"Fernando","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0300","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2990.2007.00828.x","article-title":"White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses","volume":"33","author":"Simpson","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0305","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.2009.172072","article-title":"Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis","volume":"81","author":"Topakian","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17116\/jnevro201811812223","article-title":"Biomarkers and mechanisms of early vascular damage","volume":"118","author":"Dobrynina","year":"2018","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0315","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11682-018-9855-7","article-title":"Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging","volume":"13","author":"Zhang","year":"2019","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0320","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2015.116","article-title":"Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review","volume":"36","author":"Poggesi","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0325","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00581.2016","article-title":"Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging","volume":"312","author":"Toth","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.clinbiochem.2021.07.003_b0330","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neurobiolaging.2013.08.020","article-title":"Markers of endothelial dysfunction and cerebral blood flow in older adults","volume":"35","author":"Sabayan","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.07.003_b0335","article-title":"Subklinicheskie cerebral'nye proyavleniya i porazhenie golovnogo mozga pri asimptomnoj vpervye diagnostirovannoj arterial'noj gipertenzii \u2013 article in Russian","volume":"10","author":"Dobrynina","year":"2016","journal-title":"Annaly klinicheskoj i eksperimental'noj nevrologii."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:57:29Z","timestamp":1757865449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021001922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":67,"alternative-id":["S0009912021001922"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.07.003","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-NR2 glutamate receptor antibodies as an early biomarker of cerebral small vessel disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}